Total Raised

$101.82M

Investors Count

3

Deal Terms

2

Funding, Valuation & Revenue

11 Fundings

PellePharm has raised $101.82M over 11 rounds.

PellePharm's latest funding round was a Corporate Minority for $70M on November 20, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/20/2018

Corporate Minority

$70M

$XXM

0

FY undefined

5

7/3/2018

Series C

$7.5M

Undisclosed Investors

$XXM

0

FY undefined

1

7/31/2017

Series B - III

$12.2M

$XXM

0

FY undefined

3

8/17/2016

Series B - II

$XXM

$XXM

0

FY undefined

10

10/14/2015

Unattributed - III

$XXM

$XXM

0

FY undefined

10

Date

11/20/2018

7/3/2018

7/31/2017

8/17/2016

10/14/2015

Round

Corporate Minority

Series C

Series B - III

Series B - II

Unattributed - III

Amount

$70M

$7.5M

$12.2M

$XXM

$XXM

Investors

Undisclosed Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

5

1

3

10

10

Start free trial
New call-to-action

PellePharm Deal Terms

2 Deal Terms

PellePharm's deal structure is available for 2 funding rounds, including their Series B from July 24, 2015.

Round

Series B

Series A

Funding Date

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

PellePharm Investors

3 Investors

PellePharm has 3 investors. LEO Pharma invested in PellePharm's Corporate Minority funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/20/2018

11/20/2018

1
Corporate Minority

Corporation

Denmark

00/00/0000

00/00/0000

BridgeBio

Subscribe to see more

Corporation

California

EcoR1 Capital

Subscribe to see more

Venture Capital

California

First funding

11/20/2018

00/00/0000

Last Funding

11/20/2018

00/00/0000

Investor

BridgeBio

EcoR1 Capital

Rounds

1
Corporate Minority

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Corporation

Venture Capital

Location

Denmark

California

California

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.